RSMD Branches Out, HOPE For CAPR, Aeolus' Clinical Hold Lifted, SGEN On Track

ResMed (RMD) is all set to acquire privately held Brightree LLC, a provider of cloud-based software to improve clinical and business performance in the post-acute care industry, for $800 million in cash.

from RTT - Biotech http://ift.tt/1OrEiKI
via IFTTT